SELLAS Life Sciences (SLS) Other Working Capital Changes (2011 - 2026)
SELLAS Life Sciences (SLS) posted quarterly Other Working Capital Changes of -$159000.0 for Q1 2026, little changed year-over-year from -$159000.0 in Q1 2025, and little changed quarter-over-quarter from -$159000.0 in Q4 2025.
SELLAS Life Sciences (SLS) Other Working Capital Changes (2011 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Other Working Capital Changes for 6 consecutive years, with -$159000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes changed 0.0% year-over-year to -$159000.0; the TTM figure through Mar 2026 stood at -$635000.0 (down 13.39% YoY), while the FY2025 annual figure was -$635000.0, down 19.14% from the prior year.
- Other Working Capital Changes held at -$159000.0 in Q1 2026 per SLS's latest filing, from -$159000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.4 million in Q1 2024 and bottomed at -$1.1 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $120235.3 across 5 years, with a median of -$340000.0 in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 91.6% in 2022 and fell as far as 104.9% in 2022.
- SELLAS Life Sciences' Other Working Capital Changes stood at -$127000.0 in 2022, then retreated by 3.94% to -$132000.0 in 2023, then decreased by 2.27% to -$135000.0 in 2024, then decreased by 17.78% to -$159000.0 in 2025, then changed by 0.0% to -$159000.0 in 2026.
- Business Quant data shows SLS's Other Working Capital Changes at -$159000.0 in Q1 2026, -$159000.0 in Q4 2025, and -$158000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88,000.00 |
| Jun 30, 2026 | 88,000.00 |
| Jun 30, 2026 | 88,000.00 |
| Mar 31, 2026 | 652,000.00 |
| Mar 31, 2026 | 652,000.00 |
| Mar 31, 2026 | 652,000.00 |
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | 635,000.00 |
| Sep 30, 2025 | 635,000.00 |
| Sep 30, 2025 | 635,000.00 |
| Jun 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 291,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | -340,000.00 |
| Dec 31, 2024 | -340,000.00 |